Billionaire Profile
M.Satyanarayana Reddy
Global Rank
#1570

Image: Public domain | via Wikimedia Commons

M.Satyanarayana Reddy

CEO, MSN Laboratories
IN
Real-Time Net Worth
$2.5B
As of December 2025
Age
68
Source
Pharmaceuticals
Industry
healthcare
Citizenship
IN

Biography

M. Satyanarayana Reddy is an Indian billionaire and the Founder, Chairman, and Managing Director of MSN Group of Companies, headquartered in Hyderabad, India. Born in the Mahbubnagar district of Telangana, he started his career as a chemist after earning his Ph.D. in Organic Chemistry from Osmania University. Reddy founded MSN Labs in 2003, which has grown to become one of the fastest-growing pharmaceutical companies in India, with a focus on producing affordable generic medicines. His entrepreneurial achievements include the manufacturing of the COVID-19 drug Favilow, contributing to his estimated net worth of $2.5 billion.

Wealth Over Time

In-Depth Profile

Early Life

M. Satyanarayana Reddy, often known as Dr. MSN, was born in Gurukunta village, Mahbubnagar district, Telangana. He completed his early education in his native district. He earned a Master's degree in Organic Chemistry and a Ph.D. from Osmania University.

Rise to Success

Dr. Reddy began his career in the pharmaceutical industry in 1990, working in research and development before rising to leadership positions in Indian pharmaceutical MNCs. In 2003, he made a significant career move by establishing MSN Laboratories with an initial capital of Rs 5 crore. Under his leadership, MSN Group has expanded to include five privately held companies and 16 manufacturing facilities in India, Myanmar, and the USA.

Key Business Strategies

MSN Laboratories focuses on manufacturing affordable, high-quality generic medicines. The company has a strong research and development team and holds numerous patents for its products and processes. A key milestone was the manufacturing of Favilow, a lower-priced version of the COVID-19 drug Favipiravir. MSN Group's strategy includes expanding its global footprint, with marketing and subsidiary offices in several major markets.

Philanthropy

While specific monetary amounts are unavailable in the search results, Dr. Reddy's company has provided medical aid during the COVID-19 pandemic and has focused on making medicines affordable and accessible.

Career Milestones

1990

Began Career

Started his career in the pharmaceutical industry.

2003

Founded MSN Laboratories

Established MSN Laboratories with an initial capital of Rs 5 crore.

2020

Favilow Manufacturing

Began manufacturing Favilow, a lower-priced version of the COVID-19 drug Favipiravir.

Philanthropy & Social Impact

Healthcare

COVID-19 Medical Aid

Undisclosed

Provided medical assistance during the COVID-19 pandemic.